Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
211 Leser
Artikel bewerten:
(0)

DGAP-HV: SAF-HOLLAND S.A.: Bekanntmachung der -3-

DJ DGAP-HV: SAF-HOLLAND S.A.: Bekanntmachung der Einberufung zur Hauptversammlung am 27.04.2017 in Luxembourg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten.

DGAP-News: SAF-HOLLAND S.A. / Bekanntmachung der Einberufung zur Hauptversammlung 
SAF-HOLLAND S.A.: Bekanntmachung der Einberufung zur Hauptversammlung am 27.04.2017 in 
Luxembourg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG 
 
2017-03-28 / 15:00 
Bekanntmachung gemäß §121 AktG, übermittelt durch DGAP 
- ein Service der EQS Group AG. 
Für den Inhalt der Mitteilung ist der Emittent verantwortlich. 
 
SAF-HOLLAND S.A. 
Société anonyme Siège social: 68-70, boulevard de la Pétrusse 
L-2320 Luxembourg 
R.C.S. Luxembourg: B 113.090 
Share Capital: EUR 453,611.12 Notice to all Shareholders All shareholders of 
SAF-HOLLAND S.A. (the '*Company*') are hereby given notice 
upon instruction of the board of directors of the Company (the '*Board of 
Directors*') 
that two general meetings of shareholders shall be held on the same day as 
follows: _Annual General Meeting 2017_ 
(the '*AGM*') will be held on 27 April 2017, at _8:30 _a.m. (Central European 
Summer Time, '*CEST*') 
with the agenda as set out under I. below Please note that the AGM will 
exceptionally be held at a different time than in 
the previous year and as mentioned in the articles of association of the 
Company due to organizational reasons and an _Extraordinary General Meeting of 
Shareholders_ 
(the '*EGM*') will be held on 27 April 2017, at 9:30 a.m. (CEST) with the 
agenda as set out under 
II. below Both AGM and EGM will be held at the offices of: GSK Luxembourg SA 
44, Avenue John F. Kennedy 
2nd floor 
L-1855 Luxembourg I. AGENDA FOR THE AGM 
1.  *Presentation of the statutory management 
    report and consolidated management report 
    for the fiscal year ended 31 December 2016.* 
 
    _The Board of Directors proposes that both 
    management reports in respect of the fiscal 
    year ended 31 December 2016 be APPROVED by 
    the shareholders_. 
2.  *Presentation of the reports by the auditor 
    of the Company in respect of the statutory 
    financial statements of the Company and in 
    respect of the consolidated financial 
    statements of the Company and its group for 
    the fiscal year ended 31 December 2016.* 
 
    _The Board of Directors proposes that the 
    reports by the auditor in respect of both 
    the statutory and the consolidated financial 
    statements for the fiscal year ended 31 
    December 2016 be APPROVED by the 
    shareholders._ 
3.  *Approval of the statutory financial 
    statements of the Company for the fiscal 
    year ended 31 December 2016.* 
 
    _The Board of Directors proposes that the 
    statutory financial statements of the 
    Company for the fiscal year ended 31 
    December 2016 be APPROVED by the 
    shareholders._ 
4.  *Approval of the consolidated financial 
    statements of the Company and its group for 
    the fiscal year ended 31 December 2016.* 
 
    _The Board of Directors proposes that the 
    consolidated financial statements of the 
    Company and its group for the fiscal year 
    ended 31 December 2016 be APPROVED by the 
    shareholders._ 
5.  *Resolution concerning the allocation of the 
    results of the Company for the fiscal year 
    ended 31 December 2016 and approval of 
    distributions.* 
 
    The profit for the 2016 financial year 
    amounts to EUR 19,958,352.70. The Board of 
    Directors proposes to the shareholders to 
    distribute EUR 19,958,889.28 of the profit 
    by paying a dividend in cash to the 
    shareholders of EUR 0.44 per share, and to 
    use an amount of EUR 536.58 from profits 
    brought forward from the previous financial 
    year for dividend distribution. The 
    aforementioned dividend distributions shall 
    be due on April 28, 2017. 
6.  *Discharge of each of the persons that have 
    acted as director of the Company during the 
    fiscal year ended on 31 December 2016, i.e. 
    Bernhard Schneider, Martina Merz, Samuel 
    Martin, Detlef Borghardt, Martin 
    Kleinschmitt, Anja Kleyboldt and Jack 
    Gisinger.* 
 
    _The Board of Directors proposes that the 
    shareholders APPROVE the discharge of each 
    of the persons who has acted as director 
    during the fiscal year ended 31 December 
    2016 with view to their mandate._ 
7.  *Discharge to the external auditor of the 
    Company, PricewaterhouseCoopers Société 
    coopérative, for and in connection with 
    their mandate carried out as external 
    auditor pertaining to the fiscal year ended 
    31 December 2016.* 
 
    _The Board of Directors proposes that the 
    shareholders APPROVE the discharge to 
    PricewaterhouseCoopers Société coopérative 
    for, and in connection with, the audit of 
    the fiscal year ended 31 December 2016._ 
8.  *Approval and renewal of the mandate of Mr. 
    Detlef Borghardt as member of the Board of 
    Directors.* 
 
    The Board of Directors proposes to approve 
    the renewal of the mandate as member of the 
    Board of Directors of the Company of Detlef 
    Borghardt, whose mandate terminates on the 
    date of the AGM (as defined above), starting 
    on 27 April 2017 after the AGM until the 
    date of the annual general meeting that will 
    resolve on the annual accounts for the 
    fiscal year ending on 31 December 2019. 
9.  *Approval of the appointment of Mr. Jack 
    Gisinger as new member of the Board of 
    Directors.* 
 
    The Board of Directors appointed Mr. Jack 
    Gisinger as member of the Board of Directors 
    by way of co-optation on 6 December 2016. It 
    is proposed that this appointment shall be 
    ratified by the AGM and Mr. Jack Gisinger 
    appointment as member of the Board of 
    Directors shall run until the date of the 
    annual general meeting that will resolve on 
    the annual accounts for the fiscal year 
    ending on 31 December 2019. 
10. *Approval and appointment of Mr. Carsten 
    Reinhardt as new member of the Board of 
    Directors.* 
 
    _The Board of Directors proposes to appoint 
    Carsten Reinhardt as member of the Board of 
    Directors until the date of the annual 
    general meeting that will resolve on the 
    annual accounts for the fiscal year ending 
    on 31 December 2019._ 
11. *Acknowledgment of the resignation of Mr. 
    Bernhard Schneider and Mr. Sam Martin as 
    members of the Board of Directors.* 
 
    _The Board of Directors acknowledges the 
    resignation of Bernhard Schneider and Samuel 
    Martin from their office as director of the 
    Company with effect as of 27 April 2017 
    after the AGM._ 
 
    _Provided that the above proposals 8. 
    through 11 of the Board of Directors are 
    approved by the AGM, the Board of Directors 
    will consist of the following members 
    starting on 27 April 2017:_ 
 
    - _Detlef Borghardt_ 
    - _Jack Gisinger_ 
    - _Martin Kleinschmitt_ 
    - _Anja Kleyboldt_ 
    - _Martina Merz_ 
    - _Carsten Reinhardt_ 
12. *Renewal of the mandate of the external 
    auditor of the Company, 
    PricewaterhouseCoopers Société coopérative 
    until the ordinary annual general meeting of 
    the shareholders of the Company in respect 
    of the fiscal year ending on 31 December 
    2017.* 
 
    _The Board of Directors proposes that 
    PricewaterhouseCoopers Société coopérative 
    be re-appointed as external auditors until 
    the ordinary annual general meeting of the 
    shareholders of the Company in respect of 
    the fiscal year ended on 31 December 2017._ 
 
*Quorum and majority requirements* 
 
There is no quorum of presence requirement for the AGM. The agenda items are 
adopted by a simple majority of the voting rights duly present or represented. 
 
*Share capital and voting rights* 
 
At the date of convening of the AGM, the Company's subscribed share capital 
equals EUR 453,611.12 and it is divided into 45,361,112 shares having a par 
value of EUR 0.01 each, all of which are fully paid up. 
 
*Available information and documentation* 
 
The following information is available on the Company's website under 
https://corporate.safholland.com/en/investor-relations/general-meeting/annual- 
general-meeting/2017 starting on the day of publication of this convening 
notice in the _Luxembourg official gazette RESA_ and at the Company's 
registered office in Luxembourg: 
 
 a) full text of any document to be made 
    available by the Company at the AGM 
    including draft resolutions in relation 
    to above agenda points to be adopted at 
    the AGM (i.e. _inter alia_ the annual 
    report containing the 2016 annual 
    financial statements, the management 
    reports and the auditor reports on the 
    statutory and consolidated accounts); 
 b) this convening notice; 
 c) the total number of shares and attached 
    voting rights issued by the Company as of 
    the date of publication of this convening 
    notice; 
 d) the proxy form as further mentioned 
    below; 
 e) CVs of new members of the Board of 
    Directors; and 
 f) the correspondence voting form as further 
    mentioned below. 
 
*Attendance and registration procedures* 
 
Shareholders are obliged to obtain an attestation from their depository bank 
('*Attestation*') which is safe-keeping their shares in the Company stating 
the number of shares held by the shareholder 14 calendar days before the date 
of the AGM ('*Record Date*'), i.e. on 13 April 2017 at 11:59 p.m. (CEST). The 
Attestation must be dispatched by fax and the original by regular mail to: 
 
*SAF-HOLLAND S.A.* 
c/o LINK Market Services GmbH 
Landshuter Allee 10 
80637 Munich 
Germany 
Fax: +49 (0)89 210 27-289 
 
The attestation must be made in text form in German or English. 
 
Attestations must be received by the Company (by fax) at the latest on the 20 
April 2017 at 11:59 p.m. (CEST). Exercise of voting rights of shares in 
connection with late Attestations will not be possible at the AGM. Upon 

(MORE TO FOLLOW) Dow Jones Newswires

March 28, 2017 09:01 ET (13:01 GMT)

DJ DGAP-HV: SAF-HOLLAND S.A.: Bekanntmachung der -2-

receipt of the Attestation within the given deadline the Company will presume 
that such shareholder will attend and vote at the Meeting by issuing the 
admission ticket. 
 
*Proxy voting representatives* 
 
Shareholders not being able to attend the AGM in person may appoint a 
proxyholder to attend the AGM on their behalf. The proxyholder will have to 
identify himself by presenting a valid identification card and by submitting 
the admission ticket of the shareholder. 
 
In order to simplify the execution of their voting rights, the Company 
provides the option of appointing a proxy voting representative named by the 
Company and bound by the instructions of the shareholder prior to the AGM. 
 
Proxy forms are available under the following contact details: 
 
*SAF-HOLLAND S.A.* 
c/o LINK Market Services GmbH 
Landshuter Allee 10 
80637 Munich 
Germany 
Fax: +49 (0)89 210 27-289 
E-Mail: agm@linkmarketservices.de 
Website: 
https://corporate.safholland.com/en/investor-relations/general-meeting/annual- 
general-meeting/2017 
In such proxy form shareholders are kindly invited to fill in the required 
details, to date, sign and return the proxy form (including the Attestation) 
by e-mail or fax and the original by mail to: 
 
*SAF-HOLLAND S.A.* 
c/o LINK Market Services GmbH 
Landshuter Allee 10 
80637 Munich 
Germany 
Fax: +49 (0)89 210 27-289 
E-Mail: agm@linkmarketservices.de 
 
The duly filled in and signed proxy form (by fax or e-mail) must be received 
by the Company at the latest on the 20 April 2017 at 11:59 p.m. (CEST). 
Exercise of voting rights of shares in connection with duly filled in and 
signed proxy forms received after such date will not be possible at the AGM. 
 
Shareholders who will receive their admission tickets by mail will receive a 
form for proxy voting. Forms for proxy voting can also be downloaded on the 
Company's website at 
https://corporate.safholland.com/en/investor-relations/general-meeting/annual- 
general-meeting/2017. In addition, forms will be sent upon written request to 
the Company at the following address: 
 
*SAF-HOLLAND S.A.* 
c/o LINK Market Services GmbH 
Landshuter Allee 10 
80637 Munich 
Germany 
Fax: +49 (0)89 210 27-289 
 
*Vote by correspondence* 
 
Shareholders who wish to vote by correspondence must request a form for voting 
by correspondence from the Company at the following address: 
 
*SAF-HOLLAND S.A.* 
c/o LINK Market Services GmbH 
Landshuter Allee 10 
80637 Munich 
Germany 
Fax: +49 (0) 89 210 27-289 
 
or, alternatively, download the form from the Company's website at 
https://corporate.safholland.com/en/investor-relations/general-meeting/annual- 
general-meeting/2017 and send the duly completed and signed form to the above 
mentioned address so that it shall be received by the Company on the 20 April 
2017 at 11:59 p.m. (CEST). Exercise of voting rights of shares in connection 
with duly filled in and signed proxy forms received after such date will not 
be possible at the AGM. 
 
*Additional important information for shareholders* 
 
Shareholders are hereby informed that exercise of voting rights is exclusively 
reserved to such persons that were shareholders on the Record Date (or their 
duly appointed proxyholders). Transfer of shares after the Record Date is 
possible subject to usual transfer limitations, as applicable. However, any 
transferee having become owner of the shares after the Record Date has no 
right to vote at the AGM. 
 
One or more shareholder(s) representing at least 5% of the Company's share 
capital may request the addition of items to the agenda of the AGM by sending 
such requests at the latest until 5 April 2017 at 11:59 p.m. (CEST) to the 
following e-mail address, fax number or mail address: 
 
*SAF-HOLLAND S.A.* 
c/o LINK Market Services GmbH 
Landshuter Allee 10 
80637 Munich 
Germany 
Fax: +49 (0)89 210 27-289 
E-Mail: agm@linkmarketservices.de 
 
Such request will only be accepted by the Company provided it includes (i) the 
wording of the agenda point, (ii) the wording of a proposed resolution 
pertaining to such agenda point, and (iii) an e-mail address and a postal 
address to which the Company may correspond and confirm receipt of the 
request. 
 
This convening notice was dispatched by e-mail to (i) registered shareholders 
that were known by name and address to the Company on 28 March 2017, (ii) the 
members of the Board of Directors of the Company and (iii) the auditor of the 
Company. 
 
Subject to compliance with the threshold notification obligations provided for 
by the Luxembourg law of 11 January 2008 on transparency requirements for 
issuers of securities, there is no limit to the maximum number of votes that 
may be exercised by the same person, whether in its own name or by proxy. 
 
The results of the vote will be published on the Company's website within 15 
days following the AGM. 
 
For further information you may contact the service provider, LINK Market 
Services GmbH, by dialling +49 (0)89 210 27-222 (Mon. - Fri. 9 a.m. to 5 p.m. 
CEST, except on public holidays in Luxembourg as well as in Germany). 
 
*Luxembourg, in March 2017* 
 
SAF-HOLLAND S.A. The Board of Directors 
II. Agenda for the EGM 
 
*1. Renewal and use of the Authorised Share Capital I of the Company* 
 
_The Board of Directors proposes to renew the Remaining Amount (as defined in 
the articles of association of the Company,_ '_Articles_') of the Authorised 
Share Capital I of the Company with its current amount of EUR 119,588.52 
consisting of 11,958,852 shares having a par value of EUR 0.01 each to be 
issued with or without issue share premium. The Board of Directors shall be 
empowered to use the Remaining Amount of the authorised share capital until 
and including the 5th anniversary of the date of publication of the notarial 
deed of this EGM or a subsequent 2nd extraordinary general meeting, as 
applicable, in the RESA and respective restatement of Article 5.3.6 of the 
Articles as follows: 
 
 '_5.3.6_ _The time period for the 
          authorisation to use the Remaining 
          Amount shall end on the 5th 
          anniversary of the date of 
          extraordinary general meeting 
          having last amended this article 
          5.3.6._' 
 
_Furthermore, the Board of Directors proposes that EUR 45,361.11 of the 
Remaining Amount shall be allocated to the Special Amount as to allow to issue 
additional 4,536,111 new shares (such amount being 10% of the issued share 
capital of the Company on 21 December 2015) without such issue being subject 
to any preferential subscription rights of existing shareholders (_'_New 
Special Amount_'_). For this New Special Amount the authorisation period as 
mentioned in Art. 5.3.6 above shall apply. As a result the total Special 
Amount is EUR 90,722.22 allowing the issue of 9,072,222 new shares without 
preferential subscription rights while the total Remaining Amount is EUR 
74,227.41 allowing to issue 7,422,741 new shares by respecting preferential 
subscription rights of existing shareholders._ 
 
_Articles 5.3.3. and 5.3.4 shall hence be reworded as follows:_ 
 
 _5.3.3_ Until and including 21 December 2015 
         the Board of Directors has used the 
         Authorised Share Capital I so that 
         the amount that may still be used 
         for capital increases amounts to one 
         hundred sixty-four thousand nine 
         hundred forty-nine Euro and 
         sixty-three cents (EUR 164,949.63). 
         From such remaining amount, the 
         Board of Directors shall be 
         permitted to use up to EUR 90,722.22 
         for issuing 9,072,222 new shares 
         (such amount being 20% of the issued 
         share capital of the Company on 21 
         December 2015) without such issue 
         being subject to any preferential 
         subscription rights of existing 
         shareholders ('_Special Amount_'_). 
         In addition, the issue price for the 
         newly issued shares out of the 
         Special Amount shall not be 
         significantly lower than the stock 
         exchange price of the Company's 
         shares already listed._ 
 _5.3.4_ _The remaining amount of the then 
         still available Authorised Share 
         Capital I being EUR 74,227.41 
         representing 7,422,741 newly issued 
         shares (_'_Remaining Amount_'_) may 
         be issued by the Board of Directors 
         only by respecting the preferential 
         subscription rights of existing 
         shareholders._ 
 _5.3.5_ Furthermore, the authorisation to 
         use EUR 45,361.11 out of the Special 
         Amount in the manner mentioned above 
         shall be renewed and be valid for a 
         period of five (5) years starting 
         with the day of publication of the 
         notarial deed pertaining to an 
         extraordinary general meeting of 
         shareholders of the Company signed 
         on 22 December 2015 or the notarial 
         deed of any subsequent extraordinary 
         general meeting of shareholders, as 
         applicable, in the official 
         Luxembourg gazette RESA. Pertaining 
         to the rest of the Special Amount 
         amounting to EUR 45,361.11 the 
         authorisation period as mentioned in 
         Article 5.3.6 shall apply. 
 
*2. Renewal of Authorised Share Capital I of the Company (Alternative agenda 
point in relation to agenda point 1. above)* 
 
_In the case that Agenda Point 1 above is not adopted by the shareholders this 
Agenda Point 2 shall be proposed for approval to the General Meeting (for sake 
of clarity: in case Agenda point 1 is duly adopted than this Agenda point 2 
will not be proposed for approval to the General Meeting but is redundant):_ 
 
_The Board of Directors proposes to renew the Remaining Amount (as defined in 
the articles of association of the Company,_ '_Articles_') of the Authorised 
Share Capital I of the Company with its current amount of EUR 119,588.52 
consisting of 11,958,852 shares having a par value of EUR 0.01 each to be 
issued with or without issue share premium. The Board of Directors shall be 

(MORE TO FOLLOW) Dow Jones Newswires

March 28, 2017 09:01 ET (13:01 GMT)

empowered to use the Remaining Amount of the authorised share capital until 
and including the 5th anniversary of the date of publication of the notarial 
deed of this EGM or a subsequent 2nd extraordinary general meeting, as 
applicable, in the RESA and respective restatement of Article 5.3.6 of the 
Articles as follows: 
 
 '_5.3.6_ _The time period for the 
          authorisation to use the Remaining 
          Amount shall end on the 5th 
          anniversary of the date of 
          extraordinary general meeting 
          having last amended this article 
          5.3.6._' 
 
*3. Renewal of the share buy-back programme of the Company* 
 
_The Board of Directors proposes:_ 
 
(i)   _To renew the share buy-back programme 
      (the_ '_Buy-Back_'_) having been approved 
      by the shareholders during the 
      extraordinary general meeting held on 26 
      April 2012. The buy-back programme shall 
      be valid until and including the 5th 
      anniversary of the date of publication of 
      the notarial deed of this EGM or a 
      subsequent 2nd extraordinary general 
      meeting, as applicable, in the RESA 
      approving the renewal of the buy-back 
      programme._ 
(ii)  _To authorize and delegate all necessary 
      powers to the Board of Directors of the 
      Company to acquire shares of the Company 
      from the shareholders of the Company 
      without cancellation of the acquired 
      shares (the_ '_New Buy-Back_'_)._ 
(iii) _Determine the general conditions of the 
      New Buy-Back being:_ 
 
       a. _that the Board of Directors shall be 
          empowered to buy-back shares of the 
          Company in the maximum amount of 10% 
          of the share capital of the Company 
          existing at the date of the 
          resolutions of the Board of Directors 
          to buy-back shares of the Company;_ 
       b. _that the Board of Directors shall be 
          authorized to effect the Buy-Back for 
          a period of time starting on the date 
          of the EGM and ending on the calendar 
          day before the fifth anniversary of 
          the date of the EGM; and_ 
       c. that in case of a Buy-Back (i) via 
          the Frankfurt stock exchange, the 
          consideration paid by the Company per 
          share (excluding incidental purchase 
          costs) may not exceed or fall below 
          the purchase price of the Xetra 
          trading system (or any other 
          comparable successor system) as 
          determined by the opening auction of 
          the stock exchange trading day on 
          which the offer is made by more than 
          10%, and (ii) via a public bid, the 
          offered purchase price or the 
          purchase price margin thresholds per 
          share (excluding incidental purchase 
          costs) may not exceed or fall below 
          the average price of the closing 
          prices of the Xetra trading system 
          (or any other comparable successor 
          system) on the three stock exchange 
          trading days preceding the day on 
          which the offer and the request to 
          the public to make an offer, 
          respectively, is publicly announced 
          by more than 15%. 
       d. _the Board of Directors is empowered 
          to buy-back shares of the Company 
          fully or partially, by one single 
          transaction or several transactions, 
          for one single purpose or for several 
          purposes or by third parties on 
          behalf, and in the interest of, the 
          Company._ 
       e. _the Board of Directors is empowered 
          to buy-back the shares of the Company 
          via the Frankfurt stock exchange or a 
          public bid._ 
(iv)  _To authorize the Board of Directors to 
      take all measures and execute any 
      formalities which may be necessary in 
      relation to the above items and the New 
      Buy-Back._ 
 
*4. Amendment of the requirements for the dismissal of Board Members* 
 
_The Board of Directors proposes to change the requirements for the dismissal 
of members of the Board of Directors and respectively to restate article 7.1 
of the Articles as follows:_ 
 
 '7.1 _The Company shall be managed by a 
      Board of Directors to be composed of at 
      least three (3) members. The directors 
      of the Company may be shareholders or 
      not. Directors may be dismissed at any 
      time with or without cause at the sole 
      discretion of the General Meeting 
      requiring a decision by at least 2/3 of 
      the existing voting rights issued by 
      the Company._' 
 
_Quorum and majority requirements_ 
 
The EGM will be duly constituted if at least half (50%) of the issued share 
capital of the Company is present or represented. The items on the agenda of 
the EGM require approval by at least 2/3 of the voting rights present or 
represented and duly expressed during the EGM. 
 
*Share capital and voting rights* 
 
At the date of convening of the EGM, the Company's subscribed share capital 
equals EUR 453,611.12 and it is divided into 45,361,112 shares having a par 
value of EUR 0.01 each, all of which are fully paid up. 
 
*Suppression and/or limitation of preferential subscription rights* 
 
In accordance with applicable Luxembourg law shareholders are hereby informed 
that the above agenda under II. includes the right to be granted to the Board 
of Directors of the Company to limit or suspend any and all existing 
preferential subscription rights of existing shareholders of the Company in 
case the Board of Directors makes use of the authorised share capital in the 
future. Details for justifying the granting of such rights will be provided at 
the EGM in the form as required under Luxembourg law. 
 
*Available information and documentation* 
 
The following information is available on the Company's website under 
https://corporate.safholland.com/en/investor-relations/events/annual-general-m 
eeting/extraordinary-general-meeting/2017 starting on the day of publication 
of this convening notice in the Luxembourg official gazette RESAand at the 
Company's registered office in Luxembourg: 
 
 a) full text of any document to be made 
    available by the Company at the EGM 
    including draft resolutions in relation 
    to above agenda points to be adopted at 
    the EGM (i.e. inter aliathe amended draft 
    articles of association); 
 b) this convening notice; 
 c) the total number of shares and attached 
    voting rights issued by the Company as of 
    the date of publication of this convening 
    notice; 
 d) the proxy form as further mentioned 
    below; and 
 e) the correspondence voting form as further 
    mentioned below. 
 
*Attendance and registration procedures* 
 
Shareholders are obliged to obtain an attestation from their depository bank 
('*Attestation*') which is safe-keeping their shares in the Company stating 
the number of shares held by the shareholder 14 calendar days before the date 
of the EGM ('*Record Date*'), i.e. on 13 April 2017 at 11:59 p.m. (CEST). The 
Attestation must be dispatched by fax and the original by regular mail to: 
 
*SAF-HOLLAND S.A.* 
c/o LINK Market Services GmbH 
Landshuter Allee 10 
80637 Munich 
Germany 
Fax: +49-89-210-27-289 
 
The attestation must be made in text form in German or English. 
 
Attestations must be received by the Company (by fax) at the latest on the 20 
April 2017 at 11:59 p.m. CEST. Exercise of voting rights of shares in 
connection with late Attestations will not be possible at the EGM. Upon 
receipt of the Attestation within the given deadline the Company will presume 
that such shareholder will attend and vote at the Meeting. 
 
*Proxy voting representatives* 
 
Shareholders not being able to attend the EGM in person may appoint a 
proxyholder to attend the EGM on their behalf. The proxyholder will have to 
identify himself by presenting a valid identification card and by submitting 
the admission ticket of the shareholder. 
 
In order to simplify the execution of their voting rights, the Company 
provides the option of appointing a proxy voting representative named by the 
Company and bound by the instructions of the shareholder prior to the EGM. 
 
Proxy forms are available under the following contact details: 
 
*SAF-HOLLAND S.A.* 
c/o LINK Market Services GmbH 
Landshuter Allee 10 
80637 Munich 
Germany 
Fax: +49-89-210-27-289 
E-Mail: agm@linkmarketservices.de 
Website:https://corporate.safholland.com/en/investor-relations/events/annual-g 
eneral-meeting/extraordinary-general-meeting/2017 
 
In such proxy form shareholders are kindly invited to fill in the required 
details, to date, sign and return the proxy form including the Attestation by 
e-mail or fax and the original by mail to: 
 
*SAF-HOLLAND S.A.* 
c/o LINK Market Services GmbH 
Landshuter Allee 10 
80637 Munich 
Germany 
Fax: +49-89-210-27-289 
E-Mail: agm@linkmarketservices.de 
 
The duly filled in and signed proxy form (by fax or e-mail) must be received 
by the Company at the latest on the 20 April 2017 at 11:59 p.m. CEST. Exercise 
of voting rights of shares in connection with duly filled in and signed proxy 
forms received after such date will not be possible at the EGM. 
 
Shareholders who will receive their admission tickets by mail will receive a 
form for proxy voting. Forms for proxy voting can also be downloaded on the 
Company's website at 
https://corporate.safholland.com/en/investor-relations/events/annual-general-m 
eeting/extraordinary-general-meeting/2017 . In addition, forms will be sent 
upon written request to the Company at the following address: 
 
*SAF-HOLLAND S.A.* 
c/o LINK Market Services GmbH 
Landshuter Allee 10 
80637 Munich 
Germany. 
Fax: +49 (0)89 210 27-289 
 
*Vote by correspondence* 
 
Shareholders who wish to vote by correspondence must request a form for voting 
by correspondence from the Company at the following address: 
 
*SAF-HOLLAND S.A.* 
c/o LINK Market Services GmbH 
Landshuter Allee 10 
80637 Munich 
Germany 
Fax: +49 (0)89 210 27-289 
 

(MORE TO FOLLOW) Dow Jones Newswires

March 28, 2017 09:01 ET (13:01 GMT)

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.